| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Dec 23, 2025 | OptimizeRx Corp | Chief Finance & Strat Officer | Sell | 46.3 | -3,658 | -2.88% | ✗ | $46.6K |
| Dec 19, 2025 | Dec 23, 2025 | OptimizeRx Corp | Chief Finance & Strat Officer | Sell | 46.3 | -1,388 | -1.08% | ✗ | $18.8K |
| Dec 19, 2025 | Dec 22, 2025 | OptimizeRx Corp | Chief Finance & Strat Officer | Sell | 46.3 | -1,388 | -1.08% | ✗ | $18.8K |
| Oct 3, 2025 | Oct 7, 2025 | OptimizeRx Corp | Chief Finance & Strat Officer | Sell | 42.5 | -4,406 | -3.46% | ✗ | $82.6K |
| Feb 15, 2025 | Feb 20, 2025 | OptimizeRx Corp | CFO | Sell | 46.3 | -2,156 | -2.22% | ✗ | $14.3K |
| Dec 19, 2024 | Dec 20, 2024 | OptimizeRx Corp | CFO | Sell | 47.5 | -1,316 | -3.41% | ✗ | $6.3K |
| Oct 11, 2024 | Oct 15, 2024 | OptimizeRx Corp | CFO | Sell | 46.3 | -2,066 | -5.83% | ✗ | $13.7K |
| Oct 3, 2024 | Oct 7, 2024 | OptimizeRx Corp | CFO | Sell | 46.3 | -4,177 | -13.31% | ✗ | $32.7K |
| Oct 11, 2022 | Apr 22, 2024 | OptimizeRx Corp | CFO | Sell | 42.5 | -3,539 | -31.54% | ✗ | $53.7K |
| Oct 11, 2022 | Oct 12, 2023 | OptimizeRx Corp | CFO | Sell | 46.3 | -2,066 | -6.54% | ✗ | $14.8K |
| Oct 3, 2023 | Oct 6, 2023 | OptimizeRx Corp | CFO | Sell | 46.3 | -4,117 | -19.29% | ✗ | $29.1K |
| Oct 11, 2022 | Mar 30, 2023 | OptimizeRx Corp | CFO | Sell | 42.5 | -6,539 | -58.27% | ✗ | $99.2K |
| Aug 15, 2022 | Aug 17, 2022 | OptimizeRx Corp | CFO | Buy | 91.3 | +3,000 | 100.00% | ✗ | $46.3K |